This document guides health care providers on the use of the lateral flow lipoarabinomannan assay (LF-LAM) for the diagnosis and management of active tuberculosis in people living with HIV (PLHIV). This guidance document further provides a summary of changes adopted from recommendations by the WHO policy update (2019), on the LF-LAM assay for the diagnosis of active tuberculosis in people living with HIV.